Preferences, beliefs, and demand for vaccines

How to cite

Sydnor, Justin; Sacks, Daniel. 2024. "Preferences, beliefs, and demand for vaccines." AEA RCT Registry. AEARCTR-0014763. https://doi.org/10.1257/rct.14763-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Justin Sydnor* , Daniel Sacks

* Primary investigator

Registry ID
AEARCTR-0014763
DOI
https://doi.org/10.1257/rct.14763-1.0
First registered
Last updated
Status
In development
Trial dates
2024-11-04 – 2024-12-16
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/14763

Abstract

Abstract hidden while study is in the field.

Intervention

Details of the interventions are kept in the Hidden Section while the study is in the field.

Experimental design

Details of the experimental design are kept in the Hidden Portion while the study is in the field.

Design details

Randomization method
Computer randomization via random number generator in Qualtrics. Randomization to the information vs. no-information conditions about population-level flu incidence and vaccine effectiveness will be 50% to each arm. Randomization to the bonus incentive questions will be 49% to $1.50 incentive; 1% on $3; 25% to $10 incentive; 24% to $20 incentive and 1% on $50 incentives.
Randomization unit
Individual level.
Clusters
Our sample size is implicitly determined by our budget of $36,000. We do not know our cost per subject ex-ante because it depends in part on subject choices. To maximize enrollment within our budget we will recruit in waves that follow each other quickly in time. After each wave we will calculate "maximum cost", which assumes that everyone responds to the wave 2 survey and earns the maximum possible bonus they are eligible (determined by combination of randomization and subject choices). We will continue adding waves until we exhaust the budget. No analysis will be done on the survey 1 data until all waves have been completed. We are anticipating total enrollment of approximately 2,800 subjects.
Observations
See note for planned clusters. Will be the same since unit of analysis is individual.
Arms
1. The information treatment arms will each target 50% of the total enrolled sample 2. The bonus incentives for vaccination will be randomized among those who state they have not been vaccinated prior to the study and those who are not contraindicated for the vaccine. The share of the overall enrolled sample eligible for randomization is not known for sure, but based on pilot surveys we estimate that it will be 75% (~2,100). From that sample, individuals will be randomized to incentive bonus eligibility at rates of 49% for $1.50; 1% for $3; 25% for $10; 24% for $20; and 1% for $50.
Primary outcomes
1. Conjoint-model estimated WTA for vaccination at both subjective and objective rates for vaccine characteristics. 2. Reported belief in percentage reduction in chance of getting the flu with vaccine (perceived effectiveness) 3. Reported belief in difference in likelihood of experiencing illness consistent with severe side effects if vaccinating relative to if not (perceived severe side-effect rate). 4. WTA switching point for vaccination in incentivized bonus choices. 5. Vaccination status at end-line survey 6. Reported experience of illness consistent with vaccine side effects at endline survey.
Secondary outcomes
Stated beliefs about own likelihood in absence of vaccination of contracting the flu, having a severe case of the flu, being hospitalized for the flu, and dying from the flu.

Cited by

No citation data available for this registration yet.

Keywords